Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HLA-C antibodies are associated with irreversible rejection in kidney transplantation: Shared molecular eplets characterization.
Bosch A, Llorente S, Eguia J, Mrowiec A, Boix F, López-Hernández R, Campillo JA, Salgado G, Moya-Quiles MR, Minguela A, Jimeno L, Alvarez-López MR, Muro M. Bosch A, et al. Among authors: alvarez lopez mr. Hum Immunol. 2014 Apr;75(4):338-41. doi: 10.1016/j.humimm.2014.01.010. Epub 2014 Jan 30. Hum Immunol. 2014. PMID: 24486575
Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection.
Moya-Quiles MR, Alvarez R, Miras M, Gomez-Mateo J, Lopez-Alvarez MR, Marin-Moreno I, Martínez-Barba E, Sanchez-Mozo MP, Gomez M, Arnal F, Sanchez-Bueno F, Marin LA, Garcia-Alonso AM, Minguela A, Muro M, Parrilla P, Alonso C, Alvarez-López MR; Spanish Group of Transplant Immunology and Immunotolerance (G03/104). Moya-Quiles MR, et al. Hum Immunol. 2007 Jan;68(1):51-8. doi: 10.1016/j.humimm.2006.10.009. Epub 2006 Nov 13. Hum Immunol. 2007. PMID: 17207712
Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
Bosch A, Llorente S, Diaz JA, Salgado G, López M, Boix F, López-Hernández R, González-Soriano MJ, Campillo JA, Moya-Quiles MR, Perez-Lopez N, Minguela A, Jimeno L, Alvarez-López MR, Muro M. Bosch A, et al. Hum Immunol. 2012 May;73(5):522-5. doi: 10.1016/j.humimm.2012.02.020. Epub 2012 Mar 6. Hum Immunol. 2012. PMID: 22425738
Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre.
Muro M, Marin L, Miras M, Moya-Quiles R, Minguela A, Sánchez-Bueno F, Bermejo J, Robles R, Ramírez P, García-Alonso A, Parrilla P, Alvarez-López MR. Muro M, et al. Transpl Immunol. 2005 Jun;14(2):91-7. doi: 10.1016/j.trim.2005.03.013. Epub 2005 Apr 25. Transpl Immunol. 2005. PMID: 15935299
Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: is the relevance of HLA-A locus matching being underestimated?
Muro M, López-Álvarez MR, Campillo JA, Marin L, Moya-Quiles MR, Bolarín JM, Botella C, Salgado G, Martínez P, Sánchez-Bueno F, López-Hernández R, Boix F, Bosch A, Martínez H, de la Peña-Moral JM, Pérez N, Robles R, García-Alonso AM, Minguela A, Miras M, Alvarez-López MR. Muro M, et al. Transpl Immunol. 2012 Mar;26(2-3):88-93. doi: 10.1016/j.trim.2011.11.006. Epub 2011 Nov 23. Transpl Immunol. 2012. PMID: 22129495 Clinical Trial.
91 results